MEDICO share price & delivery %

Filings & corporate actions

17 results filed

CSV

Next results · Q2 FY27

Expected 9 Nov 2026 – 14 Nov 2026

Estimate: filed 40–45 days after quarter end, last 4 times

2026

13 AugresultsResults · Q1 FY27 · standalone-4.8%NSE
21 JulshareholdingShareholding · 30 Jun 2026+1.0%NSE
21 MayresultsResults · Q4 FY26 · standalone+1.5%NSE
17 AprshareholdingShareholding · 31 Mar 2026+4.2%NSE
12 FebresultsResults · Q3 FY26 · standalone-1.0%NSE
20 JanshareholdingShareholding · 31 Dec 2025+2.3%NSE

Reaction to results · all yearsrose on day 0 in 6 of 17 CSV

Quarter	Filed	Day 0	+5D	+20D	Rel vol
Q1 FY27	13 Aug 2026	-4.8%	-10.9%	-22.6%	1.2×
Q4 FY26	21 May 2026	+1.5%	+1.0%	-10.1%	1.9×
Q3 FY26	12 Feb 2026	-1.0%	-3.3%	-16.5%	0.1×
Q2 FY26	14 Nov 2025	-0.2%	-7.8%	-5.1%	0.2×
Q1 FY26	8 Aug 2025	-0.8%	+6.5%	-0.1%	0.7×
Q4 FY25	8 May 2025	-6.5%	+1.8%	-9.0%	0.3×
Q3 FY25	5 Feb 2025	+3.0%	-8.7%	-19.5%	1.7×
Q2 FY25	12 Nov 2024	-0.1%	-17.1%	-10.8%	3.5×
Q1 FY25	12 Aug 2024	-2.2%	-0.3%	+18.3%	0.5×
Q4 FY24	9 May 2024	+2.8%	-5.4%	-8.5%	0.9×
Q3 FY24	12 Feb 2024	+0.4%	+5.7%	+2.7%	0.9×
Q2 FY24	9 Nov 2023	+0.7%	+0.4%	+11.1%	0.8×
Q1 FY24	10 Aug 2023	-0.3%	+3.4%	-5.7%	2.4×
Q4 FY23	12 May 2023	-1.5%	+0.4%	+0.5%	0.7×
Q3 FY23	10 Feb 2023	-0.8%	+4.3%	+21.0%	0.4×
Q2 FY23	13 Nov 2022	+4.5%	+32.4%	+50.8%	1.1×
Q1 FY23	12 Aug 2022	-4.7%	-4.2%	+8.9%	3.2×
Average		-0.6%	-0.1%	+0.3%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV

Revenue YoY+81.4%

Profit YoY+38.5%

Interest cost YoY—

Revenue QoQ+22.2%

Profit QoQ-57.0%

CAGR	2Y	3Y	4Y	5Y	6Y	7Y
Revenue	—	—	—	—	—	—
Profit	—	—	—	—	—	—

Key data

CSV

Open21.94

Day range21.21 – 22.40

52-week range20.47 – 56.88

From 52w high-61.0%

RSI (14)18.5

ATR (14)2.53

Volume1.25L

Avg volume (20D)8.59L

Rel volume0.15×

Volatility (1Y)52.5%

Turnover₹27.7L

SMA 50 / 20038.96 / 42.64

Delivery percentage

Latest · 6 Oct 202652.9%

20-day avg56.7%

1-year avg62.9%

Percentile (own history)44th

Range8.3–100.0%

Sessions1,081

Over the last 20 sessions MEDICO settled 56.7% of its traded quantity, which is above average for an NSE equity. Its one-year average is 62.9%, so recent sessions are running 6.1 points lower than usual. The latest session ranks higher than 44% of the 1,081 sessions on record for it.

What delivery percentage measures Scan the whole market on delivery

IndustryPharmaceuticals

PeersDIVISLAB LAURUSLABS SUNPHARMA WOCKPHARMA DRREDDY MOREPENLAB

Performance returns

CSV

	1D	1W	1M	3M	6M	1Y
Price	+2.26%	-0.58%	-43.87%	-44.23%	-41.36%	-54.08%

Valuation

CSV

Market cap₹184 Cr

P/E (TTM)13.3

EPS (TTM)1.66

Shares outstanding8.30Cr

Listed26 May 2022

Ownership

CSV

Promoter—

Promoter Δ QoQ—

Public—

FII—

DII—

Pledged—

Quarterly results · standalone

CSV

	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Revenue (₹ Cr)	52.6	58.7	56.8	69.4
YoY chg	—	—	+37.5%	+81.4%
Net profit (₹ Cr)	2.6	2.9	5.9	2.5
YoY chg	—	—	+34.9%	+38.5%
Net margin	4.9%	4.9%	10.3%	3.6%
EPS	0.31	0.35	0.71	0.30

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 61.38% · public 38.62%

2022-062026-06

Promoter
Public and others

Promoter: 61.38%
Public: 38.62%
Promoter change: 0.00 pp
Filed: 21 Jul 2026

FII: 0.08%
DII: 0.00%
Promoter pledged: 0.00%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV

Standalone

₹ crore, as filed

	Q2 FY24	Q3 FY24	Q4 FY24^A	Q1 FY25	Q2 FY25	Q3 FY25	Q4 FY25^A	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Revenue from operations	42.4	29.8	41.3	30.8	39.3	39.5	41.3	38.3	52.6	58.7	56.8	69.4
Other income	1.0	0.3	0.6	0.3	0.7	1.4	0.3	0.7	1.7	0.7	2.9	1.2
Total income	43.3	30.0	41.9	31.1	40.0	40.9	41.6	38.9	54.4	59.4	59.7	70.6
Total expenses	40.2	28.0	37.7	28.9	37.9	37.4	35.9	36.5	50.9	55.5	51.4	67.2
└ Finance costs	0.2	0.2	0.2	0.2	0.2	0.3	0.5	0.3	0.2	0.4	0.9	0.4
└ Depreciation	0.7	0.7	0.7	0.8	0.7	0.8	0.8	0.8	0.7	0.8	0.8	0.7
Profit before tax	3.1	2.1	4.2	2.2	2.1	3.5	5.7	2.4	3.5	3.8	8.3	3.3
Tax expense	0.7	0.6	1.1	0.6	0.6	0.9	1.4	0.6	0.9	1.0	2.5	0.8
Net profit	2.4	1.4	3.1	1.6	1.6	2.6	4.3	1.8	2.6	2.9	5.9	2.5
EPS	0.29	0.17	0.37	0.19	0.19	0.32	0.52	0.22	0.31	0.35	0.71	0.30
Net margin	5.73%	4.85%	7.50%	5.13%	3.95%	6.63%	10.51%	4.75%	4.88%	4.89%	10.31%	3.63%
PBT margin	7.42%	6.93%	10.27%	7.06%	5.42%	8.86%	13.80%	6.36%	6.60%	6.53%	14.64%	4.81%
Tax rate	22.82%	29.94%	26.99%	27.41%	27.12%	25.11%	23.82%	25.30%	26.08%	25.05%	29.60%	24.60%

^A audited · ^R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 13 Aug 2026.

MEDICO at a glance

MEDICO closed at ₹22.17 on 6 Oct 2026, +2.26% on the day, -54.1% over one year, 61.0% below its 52-week high of ₹56.88.
Delivery was 52.9% of traded quantity on 6 Oct 2026, the 44th percentile of its own 1,081 sessions with a reading (20-session average 56.7%, 1-year average 62.9%).
Market capitalisation is ₹184 crore at a trailing P/E of 13.3 (trailing EPS ₹1.66).
Q1 FY27 results (standalone, filed 13 Aug 2026): revenue ₹69 crore (+81.4% year on year), net profit ₹3 crore (+38.5%); the price moved -4.8% on the first session after.
Promoters held 61.38% at 30 Jun 2026, unchanged on the previous filing.
Q2 FY27 results are expected between 9 Nov 2026 and 14 Nov 2026, going by past filing dates — an estimate, not an announcement.

About

CSV

Macro sectorHealthcare

Basic industryPharmaceuticals

ISININE630Y01024

SeriesEQ

Listed26 May 2022

History from26 May 2022

Sessions1,083

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.

More in Pharmaceuticals & Biotechnology

CSV

All Pharmaceuticals & Biotechnology stocks on the NSE All Healthcare stocks on the NSE